Vericel Corp
NASDAQ:VCEL

Watchlist Manager
Vericel Corp Logo
Vericel Corp
NASDAQ:VCEL
Watchlist
Price: 31.43 USD 4.7% Market Closed
Market Cap: 1.6B USD

EV/EBIT
Enterprise Value to EBIT

1 232.3
Current
-106.1
Median
5.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
1 232.3
=
Enterprise Value
1.5B USD
/
EBIT
1.2m USD
EBIT Growth EV/EBIT to Growth
US
Vericel Corp
NASDAQ:VCEL
Average EV/EBIT: 191.7
1 232.3
143%
8.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -191 502.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
24.8
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
19%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
14.3
12%
1.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -567.7 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.9
17%
1.2
AU
CSL Ltd
ASX:CSL
17.7
14%
1.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.5
12%
1.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -316.6 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.3 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
192.2
2-Years Forward
EV/EBIT
40.9
3-Years Forward
EV/EBIT
22.6